Most Popular
Research Trends
The Morris Water Maze: Illustrated Handbook for Researchers
Jan 10, 2023
The Morris water maze is a widely used task in behavioral neuroscience for the study of spatial learning and memory, while additionally testing endurance and physical strength. Read More >
Research Trends
Y Maze Behavioral Task: Studying the function of spatial learning and memory in Neuroscience research
Dec 29, 2022
Since animals can't speak, they can't tell you whether they remember what just happened, or what they are experiencing at this moment. The most direct way to understand what they are thinking is to observe their behaviors. Read More >
Q&A
CAR Cell Therapy Research Models: Conversation with The Experts
Dec 22, 2022
Animal models play an important role in the preclinical evaluation of cancer immunotherapy. Let's hear from the experts from Cyagen! Read More >
Breaking News
Newsletter
Cyagen and Landau Strengthen Cooperation to Accelerate the Research and Development of AI-designed AAV Gene Therapy Vectors
Dec 12, 2022
Recently, Cyagen and Guangdong Landau Biotechnology Co., Ltd. (hereinafter referred to as "Landau Biotech") strengthened their strategic partnership on the basis of the original strategic cooperation. Read More >
Research Trends
A Good Helper for SARS-CoV-2 & COVID-19 Research: Selection and Application of Mouse Models
Dec 06, 2022
Animal models have assisted researchers' understanding of COVID-19 pathogenesis and host immune response to SARS-CoV-2 infection, and are of great significance in helping the rapid development of disease preventatives, vaccines, and treatments. Read More >
Research Trends
Application of Flow Cytometry in Preclinical CAR-T Development
Nov 28, 2022
Chimeric Antigen Receptor T-Cell (CAR-T) Immunotherapy uses genetic engineering technology to transform autologous or allogeneic T cells into new killer cells targeting tumor-specific antigens, by which remarkable results have been achieved in the treatment of hematological malignancies. Read More >
Video
Newsletter
Breaking News
Q&A
The First Artificial Chief Scientific Officer: AI Marvin
Nov 21, 2022
Have you ever wondered what the future of science education looks like? Many envision a future of readily accessible science knowledge and facts presented by intelligent, interactive teachers. Read More >
Breaking News
Cyagen and Neurophth Enter Global Strategic Collaboration to Develop AI-Designed AAV Gene Therapy Vectors for Ophthalmic Disorders
Nov 08, 2022
Cyagen today announced a strategic collaboration with Neurophth Therapeutics, Inc. to co-develop next-generation AAV gene therapy vectors for specific types of genetic ophthalmic disorders. Read More >
Research Trends
Animal Welfare Focus: Humane Endpoints in Rats and Mice in Tumor Research Programs
Nov 04, 2022
In recent years, more and more people advocate the "3Rs" principle of experimental animals: Reduction, Replacement, and Refinement. Read More >
Newsletter
3rd Annual Gene Therapy for Ophthalmic Disorders Meeting in Review
Oct 31, 2022
Cyagen representatives recently attended The 3rd Annual Gene Therapy for Ophthalmic Disorders meeting with 150+ stakeholders and industry leaders in ophthalmic gene therapy. The event brought together ophthalmology experts with world-class learning tracks to address the challenges faced in the preclinical stages and in clinical development, aiming to get these drugs to the ophthalmic gene therapy patients who need them as fast as possible. Read More >